International audienceDefining thresholds of prognostic markers is essential for stratified medicine. Such thresholds are mostly estimated from purely statistical measures regardless of patient preferences potentially leading to unacceptable medical decisions. Quality-Adjusted Life-Years are a widely used preferences-based measure of health outcomes. We develop a time-dependent Quality-Adjusted Life-Years-based expected utility function for censored data that should be maximized to estimate an optimal threshold. We performed a simulation study to compare estimated thresholds when using the proposed expected utility approach and purely statistical estimators. Two applications illustrate the usefulness of the proposed methodology which was im...
Treatment thresholds based on risk predictions can be optimized by considering various health (econo...
New prognostic models are traditionally evaluated using measures of discrimination and risk reclassi...
The question of how individual patient data from cohort studies or historical clinical trials can be...
International audienceDefining thresholds of prognostic markers is essential for stratified medicine...
International audienceThe use of a quantitative treatment selection marker to choose between two tre...
In this dissertation, we develop three new statistical methods and estimating procedures in survival...
INTRODUCTION: Treatment thresholds based on risk predictions can be optimized by considering various...
The conventional approach to comparing a new treatment with a standard therapy is often based on a s...
Stratified medicine has tremendous potential to deliver more effective therapeutic intervention to i...
International audienceObjectives: Predicting chronic disease evolution from a prognostic marker is a...
Treatment thresholds based on risk predictions can be optimized by considering various health (econo...
New prognostic models are traditionally evaluated using measures of discrimination and risk reclassi...
The question of how individual patient data from cohort studies or historical clinical trials can be...
International audienceDefining thresholds of prognostic markers is essential for stratified medicine...
International audienceThe use of a quantitative treatment selection marker to choose between two tre...
In this dissertation, we develop three new statistical methods and estimating procedures in survival...
INTRODUCTION: Treatment thresholds based on risk predictions can be optimized by considering various...
The conventional approach to comparing a new treatment with a standard therapy is often based on a s...
Stratified medicine has tremendous potential to deliver more effective therapeutic intervention to i...
International audienceObjectives: Predicting chronic disease evolution from a prognostic marker is a...
Treatment thresholds based on risk predictions can be optimized by considering various health (econo...
New prognostic models are traditionally evaluated using measures of discrimination and risk reclassi...
The question of how individual patient data from cohort studies or historical clinical trials can be...